Skip to main content

Month: August 2020

Opthea Announces Plans to Conduct Registered Public Offering and Listing in the United States

MELBOURNE, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT) today announces that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to a potential initial public offering of American Depositary Shares (“ADSs”) in the U.S. representing Opthea’s ordinary shares, which will remain listed on the Australian Securities Exchange, and concurrent listing of the ADSs on the Nasdaq Stock Market (“Nasdaq”).  Any offering and listing of ADSs on Nasdaq would be intended to support Opthea’s product development activities, including its previously announced Phase 3 trials of OPT-302 for the treatment of wet AMD.  The number of ADSs that may be offered, the number of underlying ordinary shares that may be issued, the price for such instruments...

Continue reading

New Zealand’s DIA Selects Allot to Protect Its Citizens from Digital Child Exploitation Content

Hod Hasharon, Israel, Aug. 24, 2020 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and security-as-a-service (SECaaS) solutions for communication service providers (CSPs) and enterprises, today announced New Zealand’s Department of Internal Affairs (DIA) has awarded Allot with a contract to provide the nationwide Digital Child Exploitation Filter (DCEF). Allot SmartSentinel and ContentProtector identify and block access to internet sites that contain objectionable content relating to child sexual abuse material, as defined in the New Zealand Films, Videos and Publications Classification Act of 1993.Allot has replaced DIA’s current software with a scalable, lean, and virtual solution that is easy to use and maintain without requiring third-party oversight and...

Continue reading

Viomi Technology Co., Ltd Reports Second Quarter 2020 Unaudited Financial Results

GUANGZHOU, China, Aug. 24, 2020 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading IoT @ Home technology company in China, today announced its unaudited financial results for the second quarter ended June 30, 2020.Second Quarter 2020 Financial and Operating HighlightsNet revenues reached RMB1,684.4 million (US$238.4 million), an increase of 45.2% from the second quarter of 2019.Gross margin was 14.3%.Net income was RMB10.3 million (US$1.5 million).Non-GAAP net income1 was RMB41.5 million (US$5.9 million).Number of cumulative household users reached more than 4.2 million, compared to approximately 3.7 million as of the end of the first quarter of 2020 and approximately 2.3 million as of the end of the second quarter of 2019.Percentage of household users with at least two connected products...

Continue reading

Rovio Entertainment Corp.: Share subscriptions based on stock options 2018

Rovio Entertainment Corporation                 Stock Exchange Release       24 August 2020 at 11.45 a.m. EESTShare subscriptions based on stock options 2018Between 6 February 2020 and 6 August 2020, a total of 2,250 Rovio Entertainment Corporation’s new shares have been subscribed for with the stock option program 2018. 2,250 new shares have been subscribed for with the 2018A stock options at a subscription price of EUR 5.08. The entire subscription price of EUR 11,430.00 shall be recorded into the invested unrestricted equity reserve.As a result of the share subscriptions, the number of Rovio Entertainment shares will increase to     81,270,361 shares.The shares subscribed for under the stock options have been registered in the Trade Register on 24 August 2020, as of which date the new shares will establish shareholder rights.The shares...

Continue reading

Rovio Entertainment Oyj: Osakkeiden merkintä optio-oikeuksilla 2018

Rovio Entertainment Oyj                              Pörssitiedote                        24.8.2020 klo 11.45Osakkeiden merkintä optio-oikeuksilla 2018Rovio Entertainment Oyj:n vuoden 2018 optio-ohjelman optio-oikeuksilla on 6.2.2020 – 6.8.2020 välisenä aikana merkitty yhteensä 2 250 Rovion osaketta. Optio-oikeuksilla 2018A on merkitty 2 250 yhtiön uutta osaketta merkintähintaan 5,08 euroa. Optio-oikeuksilla tehtyjen merkintöjen merkintähinta, yhteensä 11 430,00 euroa, kirjataan kokonaisuudessaan sijoitetun vapaan oman pääoman rahastoon.Merkintöjen pohjalta Rovio Entertainment Oyj:n osakkeiden lukumäärä nousee 81 270 361 osakkeeseen.Optio-oikeuksien perusteella merkityt osakkeet on rekisteröity kaupparekisteriin 24.8.2020. Uudet osakkeet tuottavat omistajilleen osakkeenomistajan oikeudet rekisteröintipäivästä lähtien.Osakkeet ovat kaupankäynnin...

Continue reading

Laser Hair Removal Market to Hit $1,378.4 Million by 2027; Increasing Focus on Body Aesthetics Worldwide to Fuel Market Expansion: Fortune Business Insights™

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — The global laser hair removal market size is projected to reach USD 1,378.4 million by 2027, exhibiting a CAGR of 15.2% during the forecast period. Wide availability of advanced hair removal technologies will be one of the top growth drivers for this market, states Fortune Business Insights™ in its report, titled “Laser Hair Removal Market Size, Share & COVID-19 Impact Analysis, By Product (Diode, Alexandrite, Nd: YAG, and Others), By End User (Hospitals, Medical Spas & Specialty Clinics, and Others), and Regional Forecast, 2020-2027”.Laser hair removal treatments are gaining popularity owing to their proven efficacy in preventing hair growth. To capture this trend, many companies have developed a portfolio of novel hair removal systems based on laser technology. For instance, Nordlys,...

Continue reading

Preeclampsia Diagnostics Market worth USD 2.52 Billion at 11.0% CAGR by 2027; Increasing Healthcare Expenditure to Boost Growth: Fortune Business Insights™

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — The global preeclampsia diagnostics market is anticipated to gain momentum from the increasing number of pregnancies owing to the complete lockdown amid the COVID-19 pandemic. This information is given by Fortune Business Insights™ in a new report, titled, “Preeclampsia Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Test Type (Blood Tests and Urine Analysis), By Product (Instruments and Consumables) End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2027.” The report further states that this market size was USD 1.06 billion in 2019 and is projected to reach USD 2.52 billion by 2027, thereby exhibiting a CAGR of 11.0% during the forecast period.What are the challenges and opportunities in the market?What are the market dynamics,...

Continue reading

Bourse Direct est partenaire de B SMART, la chaîne des audacieux

 Bourse Direct, partenaire de B SMART, la chaîne des audacieux. Un partenariat d’envergure avec la nouvelle chaîne dédiée à l’économieLancée en juin dernier et présidée par Stéphane Soumier, la chaîne B SMART est le nouveau média d’information consacré à l’économie et à la finance. B SMART s’adresse aux décideurs, aux actifs et à tous ceux qui, en France, réfléchissent sur ce que doit être le monde de demain.Fort de cette ambition, Bourse Direct est heureuse de participer à cette aventure en apportant son expertise des marchés financiers au contenu de la chaîne.4 points bourse chaque jour pour suivre la tendance   A partir du 24 août, 4 points bourse par jour, animé par Nicolas PAGNIEZ, journaliste B SMART, seront proposés depuis la salle des marchés de Bourse Direct (9h55, 12h30, 14h55 et 18h30). Des rendez-vous incontournables...

Continue reading

ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study

SINGAPORE, Aug. 24, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the resumption of patient recruitment into its randomised, double-blind, placebo-controlled multiple ascending dose (MAD) study of ASLAN004 in moderate to severe atopic dermatitis.ASLAN paused recruitment of new patients on 13 April 2020 in line with government restrictions enforced in Singapore to contain the spread of the coronavirus disease (COVID-19). Patients are now being recruited into the second of three dose cohorts at all screening sites in Singapore. To accelerate recruitment, ASLAN is in the process of opening additional study sites in Australia and the US.ASLAN expects to...

Continue reading

Update on progress at Santa Elena mine

CABORCA, Mexico, Aug. 24, 2020 (GLOBE NEWSWIRE) — Mexus Gold US (OTCQB: MXSG) (“Mexus” or the “Company) announced an update on its 1st quarter results which ran April to June, 2020.   During this period the company established mining operations at its Santa Elena mine.  The company faced challenges during this period due to COVID-19 which included periods of shut down due to labor laws in Mexico.  Mexus was still able to produce gold and used the time to make adjustments at the mine site.  Improvements at the mine during this period included:  improving the crushing circuit to maximize efficiencies, an increase in employees to include two new equipment operators and a lab technician, and the acquisition of a 330 excavator a 40 ton haul truck and repairs to existing equipment.    The company currently has four haul trucks and three...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.